Journals / Middle Black Sea Journal of Health Science / 2021 / Cilt: 7 - Sayı: 2

In Vitro Interactions of Antibiotics with Drugs Used in Chronic Diseases

Pages
178–185
Publication Date
2021-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With the awareness that the only difference between drug and poison is the dose, all health professionals especially doctors and pharmacists and patients have a responsibility towards the rational use of drugs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this century, with the prolonged life expectancy, chronic diseases have become the most important cause of mortality and morbidity in the world and in our country.
📊
Key Findings & Data:Infections caused by resistant bacteria cause an increase in disease/death rates and treatment costs.
💡
Conclusion & Impact:With the awareness that the only difference between drug and poison is the dose, all health professionals especially doctors and pharmacists and patients have a responsibility towards the rational use of drugs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:antibiotics · chronic diseases · disk diffusion method

Abstract

Objective: In this century, with the prolonged life expectancy, chronic diseases have become the most important cause of mortality and morbidity in the world and in our country. Frequent drug-drug interactions have made it necessary to update the doses of drugs in multiple drug use. In our study, we aimed to observe how the drugs that are frequently prescribed by physicians in the treatment of chronic and infectious diseases, together with standard bacteria and fungi strains in in vitro environment, change the effects of each other.Methods: By combining antibiotic discs and drugs that are commonly used in chronic diseases (acetylsalicylic acid, amlodipine, atorvastatin, warfarin, metoprolol and clopidogrel) in in vitro environment, we determined the drug interactions (synergy/antagonism) by Kirby Bauer disk diffusion method.Results: While most of the discs placed on the culture of Candida albicans through impregnation of drugs showed potentiation synergism with itraconazole and fluconazole, other microorganisms showed synergistic and sometimes antagonistic interactions with different drugs and antibiotics, whereas some of the drugs did not show any interaction with antibiotic discs.Conclusion: Due to the strong relationship between advanced age and the number of prescribed drugs and the frequency of possible drug-drug interactions, the elderly people especially are susceptible to this situation. Infections caused by resistant bacteria cause an increase in disease/death rates and treatment costs. With the awareness that the only difference between drug and poison is the dose, all health professionals especially doctors and pharmacists and patients have a responsibility towards the rational use of drugs.

🔖

Cite This Article

ERDOĞAN, E., GÜNAL, S. (2021). In Vitro Interactions of Antibiotics with Drugs Used in Chronic Diseases. Middle Black Sea Journal of Health Science, Cilt: 7 - Sayı: 2, 178–185. https://ajindex.com/articles/791047

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. World Health Organization. Major NCDs and their risk factors 2018. https://www.who.int/ncds/introduction/en/ 23 Mart 2019
  2. World Health Organization. Major NCDs and their risk factors 2018. https://www.who.int/ncds/introduction/en/ 23 Mart 2019
  3. World Health Organization. Natıonal Household Health Survey in Turkey Prevalence of Noncommunıcable Disease Factors 2017. https://www.who.int/ncds/surveillance/steps/WHO_Turkey_Risk_Factors_A4_TR_19.06.2018.pdf 24 Mart 2019
  4. World Health Organization. Natıonal Household Health Survey in Turkey Prevalence of Noncommunıcable Disease Factors 2017. https://www.who.int/ncds/surveillance/steps/WHO_Turkey_Risk_Factors_A4_TR_19.06.2018.pdf 24 Mart 2019
  5. Snyder BD, Polasek TM, Doogue MP. Drug interactions: principles and practice. Aust Prescr.2012, 35: 85-8
  6. Snyder BD, Polasek TM, Doogue MP. Drug interactions: principles and practice. Aust Prescr.2012, 35: 85-8
  7. Stepanović S, Vuković D, Ješić M, Ranin L. Influence of acetylsalicylic acid (aspirin) on biofilm production by Candida species. J Chemother 2004, 16: 134-8
  8. Stepanović S, Vuković D, Ješić M, Ranin L. Influence of acetylsalicylic acid (aspirin) on biofilm production by Candida species. J Chemother 2004, 16: 134-8
  9. T.R. Ministry of Health. Yearbook of Health Statistics. Ankara 2016. https://dosyasb.saglik.gov.tr/Eklenti/13183,sy2016turkcepdf.pdf24 Mart 2019
  10. T.R. Ministry of Health. Yearbook of Health Statistics. Ankara 2016. https://dosyasb.saglik.gov.tr/Eklenti/13183,sy2016turkcepdf.pdf24 Mart 2019
  11. Clinical and Laboratory Standards Institute (CLSI), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard 13th Edition. CLSI Document, M02Ed13E, 1-56238-834-7 M022018.Clinical and Laboratory Standards Institute 950 West Valley Road, Suite 2500 Wayne, PA 19087 USA
  12. Clinical and Laboratory Standards Institute (CLSI), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard 13th Edition. CLSI Document, M02Ed13E, 1-56238-834-7 M022018.Clinical and Laboratory Standards Institute 950 West Valley Road, Suite 2500 Wayne, PA 19087 USA
  13. Clinical and Laboratory Standards Institute (CLSI), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard 11th Edition. CLSI Document, M02Ed13E, 1-56238-834-7M07 2018. Clinical and Laboratory Standards Institute 950 West Valley Road, Suite 2500 Wa